| Market Cap | 4.55B 4.13B 3.82B 3.45B 6.51B 427B 6.74B 45.93B 18.2B 229B 17.07B 16.71B 726B | P/E 2024 |
-51.1x | P/E 2025 | -162x |
|---|---|---|---|---|---|
| Enterprise Value | 4.7B 4.27B 3.94B 3.56B 6.72B 441B 6.96B 47.43B 18.79B 237B 17.63B 17.26B 750B | EV / Sales 2024 |
5.69x | EV / Sales 2025 | 7.18x |
| Free-Float |
99.31% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Amicus Therapeutics
| 1 day | +1.57% |
| Manager | Title | Age | Since |
|---|---|---|---|
George Davis
PSD | President | 55 | 27/04/2026 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.57% | +1.65% | - | - | 4.55B | ||
| -1.29% | -1.76% | +51.98% | +64.66% | 66.33B | ||
| -0.09% | +2.79% | +10.75% | +95.02% | 60.62B | ||
| +0.63% | +1.64% | +24.25% | +89.70% | 55.5B | ||
| -0.67% | -0.49% | +10.26% | +119.53% | 47.58B | ||
| -0.16% | -5.29% | +22.20% | +28.96% | 43.69B | ||
| -2.61% | -15.91% | +143.43% | +692.05% | 37.27B | ||
| +0.23% | +1.66% | +14.85% | +49.06% | 36.57B | ||
| +2.35% | -3.61% | +78.64% | +60.70% | 32.22B | ||
| +2.59% | +6.84% | -37.16% | +407.53% | 26.58B | ||
| Average | +0.28% | +0.33% | +35.47% | +178.58% | 45B | |
| Weighted average by Cap. | -0.05% | +0.33% | +35.28% | +153.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 528M 480M 443M 401M 756M 49.6B 783M 5.33B 2.11B 26.62B 1.98B 1.94B 84.32B | 634M 576M 532M 481M 907M 59.55B 939M 6.4B 2.54B 31.96B 2.38B 2.33B 101B |
| Net income | -56.11M -50.97M -47.1M -42.54M -80.28M -5.27B -83.1M -566M -224M -2.83B -211M -206M -8.95B | -27.11M -24.63M -22.76M -20.56M -38.79M -2.55B -40.16M -274M -108M -1.37B -102M -99.58M -4.33B |
| Net Debt | 194M 176M 163M 147M 277M 18.19B 287M 1.96B 775M 9.76B 727M 711M 30.92B | 149M 135M 125M 113M 213M 13.97B 220M 1.5B 595M 7.5B 558M 547M 23.75B |
Employees
-
















